| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.97M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 12,000 | $18.34 | $220,106.00 | -1.0% | |
| Nov 21, 2016 | Haqq Christopher | Chief Medical Officer | Sell | 7,068 | $17.85 | $126,163.80 | -1.8% | |
| Nov 17, 2016 | Soffer Gad | Chief Operating Officer | Sell | 1,480 | $18.41 | $27,246.80 | -0.6% | |
| Nov 16, 2016 | Gallagher Carol Giltner | Director | Sale+OE | 1,184 | $19.35 | $22,910.40 | -1.2% | |
| Nov 16, 2016 | Clark Mitchall G. | Chief R &Qa Officer | Sale+OE | 2,995 | $19.53 | $58,492.35 | -3.1% | |
| Nov 16, 2016 | Soffer Gad | Chief Operating Officer | Sale+OE | 16,718 | $20.00 | $334,420.82 | -3.5% | |
| Nov 15, 2016 | Haqq Christopher | Chief Medical Officer | Sale+OE | 1,604 | $19.95 | $31,999.80 | -0.4% | |
| Nov 11, 2016 | McGrath John | Chief Financial Officer | Sell | 5,000 | $19.84 | $99,175.00 | -2.7% | |
| Oct 27, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,800 | $13.81 | $66,264.00 | -0.6% | |
| Oct 14, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,800 | $15.96 | $76,608.00 | -0.6% |